Overall survival in low-comorbidity patients with stage I non–small cell lung cancer who chose stereotactic body radiotherapy compared to surgery-Reference-Cited by-同舟云学术

Overall survival in low-comorbidity patients with stage I non–small cell lung cancer who chose stereotactic body radiotherapy compared to surgery

Published:2023-07 Issue: Volume: Page:
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Udelsman Brooks V.^ORCID,Canavan Maureen E.,Zhan Peter L.,Ely Sora,Park Henry S.,Boffa Daniel J.,Mase Vincent J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference34 articles.

1. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group;Ginsberg;Ann Thorac Surg,1995

2. Non-small cell lung cancer: Role of surgery for stages I-III;Pearson;Chest,1999

3. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: NSCLC. Version 1.2022. Accessed January 12, 2022. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf

4. A national cancer database analysis of Radiofrequency ablation versus stereotactic body radiotherapy in early-stage non-small cell lung cancer;Lam;J Vasc Interv Radiol,2018

5. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline;Videtic;Pract Radiat Oncol,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insights;The Journal of Liquid Biopsy;2024-09

2. Three-year follow-up study reveals improved survival rate in NSCLC patients underwent guideline-concordant diagnosis and treatment;Frontiers in Oncology;2024-05-28

3. Commentary: Nothing is free: Surgeons' and radiation oncologists’ biases about treating early-stage lung cancer in healthy patients;The Journal of Thoracic and Cardiovascular Surgery;2023-10